parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.01 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced in astrocytes (91 nCPM)	1.00
chemistry Open Targets	a small-molecule pocket	0.60
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	1 Parkinson's papers of 34	0.91
pathways Reactome	1 pathway; mostly other	0.30

No case: the score is under the bar. Receipt 10265

receipt 10273: ACP6 in dopamine neurons, braak

power: full sample -0.06 (p 0.810, n 18), 95% CI -0.51 to +0.42. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.03 (p 0.891, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.20 (p 0.434, n 18). could be the mix.
skeptic: leave-one-out range -0.20 to +0.05, sign flips 3; without severely affected donors -0.06 (p 0.810, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ACP6 in dopamine neurons.

case closed: nothing better to follow up.

receipt 10272: ACP6 in astrocytes, braak

power: full sample +0.28 (p 0.254, n 18), 95% CI -0.21 to +0.66. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: +0.30 (p 0.228, n 18). does not hold up.
composition: astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: +0.29 (p 0.235, n 18). could be the mix.
skeptic: leave-one-out range +0.18 to +0.37, sign flips 0; without severely affected donors +0.28 (p 0.254, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for ACP6 in astrocytes.

case closed: nothing better to follow up.

loading the receipts